Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- pharma
Glyceryl STEARATE/PEG-100 stearate
CAS 84750-06-1
Concern score
Not assessed — no hazard data yet.
Why it's flagged
Route: ORAL; Dosage form: TABLET; Potency: 1.8 mg
Regulation
No restrictions found. Glyceryl STEARATE/PEG-100 stearate appears in these published regulatory listings.
- definition_level:complete
- definition_type:primary
- inactive_ingredient_database
- ingredient_type:specified substance
- substance_class:specified substance g1
- substance_type:specified substance g1
USFDAinactive ingredient database5 entries — 3 administration routes
- Route: ORAL; Dosage form: TABLET; Potency: 1.8 mgSource →
- Route: ORAL; Dosage form: TABLET, COATED; Potency: 1.8 mgSource →
- Route: RECTAL; Dosage form: SUPPOSITORY; Potency: 36 mgSource →
- Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 645 mgSource →
- Route: TOPICAL; Dosage form: LOTION; Potency: 6.5 %w/wSource →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as specifiedsubstanceg1.
- openFDA substance registry classifies this ingredient as specifiedsubstanceg1.Source →
Evidence
No graded sources yet for Glyceryl STEARATE/PEG-100 stearate. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
